Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1998-08

AUTHORS

D Damiani, M Michieli, A Ermacora, D Russo, R Fanin, F Zaja, M Baraldo, F Pea, M Furlanut, M Baccarani

ABSTRACT

P-glycoprotein (Pgp)-related multidrug resistance (MDR) is frequently observed in acute non-lymphocytic leukemia (ANLL) and is associated with a poor response to standard chemotherapy. Cyclosporin A (CsA) is an effective downmodulator of Pgp-related MDR in vitro and has already been tested for that purpose in vivo also. Since Pgp is expressed in several normal cells and tissues, the modulation of Pgp can also modify total body exposure to antileukemic drugs and can alter and increase the toxicity of the antileukemic treatment. We report here the results of a study where 46 consecutive adult patients with ANLL were assigned to receive the same standard chemotherapy regimen of arabinosyl cytosine and idarubicin (IDA) for remission induction or consolidation, without or with CsA. Twenty-eight patients received 36 courses of chemotherapy without CsA and 18 patients received 32 courses of chemotherapy with CsA. CsA dose was 10-12.5 mg/kg/day and was given as a continuous i.v. infusion for 72 h. Whole blood CsA steady-state concentration ranged between 0.61 and 1.14 microM. The IDA area-under-the-curve was about twice as high in the cases that received CsA than in the other cases. CsA had no detectable effects on renal function and fluid balance, but significantly increased systemic blood diastolic pressure and conjugated bilirubine concentration. Furthermore, CsA-treated patients had greater, and more severe, oral and intestinal mucosal toxicity, with more severe adverse events, including more cases of gram-negative bacteremia, and with a delayed hemopoietic recovery. In conclusion, this study showed that an attempt at an effective downmodulation of Pgp-mediated MDR would substantially increase the hemopoietic and mucosal toxicity of antileukemic treatment and that the increase is accounted for, at least in part, by an increase of total body exposure to IDA. More... »

PAGES

1236

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.leu.2401092

DOI

http://dx.doi.org/10.1038/sj.leu.2401092

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026512234

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9697878


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bilirubin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatinine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclosporine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytarabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Feasibility Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Idarubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Clinical and Morphologic Research, Udine University Hospital, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Damiani", 
        "givenName": "D", 
        "id": "sg:person.01104271471.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104271471.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Clinical and Morphologic Research, Udine University Hospital, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michieli", 
        "givenName": "M", 
        "id": "sg:person.0633657425.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633657425.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Department of Bone Marrow Transplantation, Udine University Hospital, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ermacora", 
        "givenName": "A", 
        "id": "sg:person.01310754205.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310754205.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Department of Bone Marrow Transplantation, Udine University Hospital, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Russo", 
        "givenName": "D", 
        "id": "sg:person.01033477037.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033477037.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Department of Bone Marrow Transplantation, Udine University Hospital, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fanin", 
        "givenName": "R", 
        "id": "sg:person.01364770162.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364770162.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Department of Bone Marrow Transplantation, Udine University Hospital, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zaja", 
        "givenName": "F", 
        "id": "sg:person.0701003563.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701003563.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Udine", 
          "id": "https://www.grid.ac/institutes/grid.5390.f", 
          "name": [
            "Chair of Pharmacology, Department of Clinical and Experimental Pathology, Udine University, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baraldo", 
        "givenName": "M", 
        "id": "sg:person.0734230340.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734230340.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Udine", 
          "id": "https://www.grid.ac/institutes/grid.5390.f", 
          "name": [
            "Chair of Pharmacology, Department of Clinical and Experimental Pathology, Udine University, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pea", 
        "givenName": "F", 
        "id": "sg:person.0725711337.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725711337.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Udine", 
          "id": "https://www.grid.ac/institutes/grid.5390.f", 
          "name": [
            "Chair of Pharmacology, Department of Clinical and Experimental Pathology, Udine University, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Furlanut", 
        "givenName": "M", 
        "id": "sg:person.01156366337.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156366337.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale Santa Maria della Misericordia di Udine", 
          "id": "https://www.grid.ac/institutes/grid.411492.b", 
          "name": [
            "Division of Hematology, Department of Clinical and Morphologic Research, Udine University Hospital, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baccarani", 
        "givenName": "M", 
        "id": "sg:person.01016466503.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016466503.33"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1073/pnas.84.21.7735", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012281167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2559.1991.tb00003.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014389362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2559.1991.tb00003.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014389362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0609.1992.tb00571.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016100757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0609.1992.tb00571.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016100757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1951.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022338973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1951.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022338973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0046-8177(90)90073-e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032819048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(91)90141-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042233556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/83.10.708", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059816490"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1992.10.10.1635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1076202587"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-08", 
    "datePublishedReg": "1998-08-01", 
    "description": "P-glycoprotein (Pgp)-related multidrug resistance (MDR) is frequently observed in acute non-lymphocytic leukemia (ANLL) and is associated with a poor response to standard chemotherapy. Cyclosporin A (CsA) is an effective downmodulator of Pgp-related MDR in vitro and has already been tested for that purpose in vivo also. Since Pgp is expressed in several normal cells and tissues, the modulation of Pgp can also modify total body exposure to antileukemic drugs and can alter and increase the toxicity of the antileukemic treatment. We report here the results of a study where 46 consecutive adult patients with ANLL were assigned to receive the same standard chemotherapy regimen of arabinosyl cytosine and idarubicin (IDA) for remission induction or consolidation, without or with CsA. Twenty-eight patients received 36 courses of chemotherapy without CsA and 18 patients received 32 courses of chemotherapy with CsA. CsA dose was 10-12.5 mg/kg/day and was given as a continuous i.v. infusion for 72 h. Whole blood CsA steady-state concentration ranged between 0.61 and 1.14 microM. The IDA area-under-the-curve was about twice as high in the cases that received CsA than in the other cases. CsA had no detectable effects on renal function and fluid balance, but significantly increased systemic blood diastolic pressure and conjugated bilirubine concentration. Furthermore, CsA-treated patients had greater, and more severe, oral and intestinal mucosal toxicity, with more severe adverse events, including more cases of gram-negative bacteremia, and with a delayed hemopoietic recovery. In conclusion, this study showed that an attempt at an effective downmodulation of Pgp-mediated MDR would substantially increase the hemopoietic and mucosal toxicity of antileukemic treatment and that the increase is accounted for, at least in part, by an increase of total body exposure to IDA.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.leu.2401092", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia", 
    "pagination": "1236", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7e4e346c34f74a04d778987742d96852a2df290e234e53bbcab80ed8e708411a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9697878"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8704895"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.leu.2401092"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026512234"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.leu.2401092", 
      "https://app.dimensions.ai/details/publication/pub.1026512234"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29219_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/2401092"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401092'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401092'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401092'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401092'


 

This table displays all metadata directly associated to this object as RDF triples.

228 TRIPLES      21 PREDICATES      54 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.leu.2401092 schema:about N108a7dec09d444b4acb03ff2eee82964
2 N2d8d323faf9343f08e81baacf1834260
3 N37cd50f1e7084af49be0284e19a52f6d
4 N4aeeeead422949cfa04df2d86049648b
5 N50383265672d4ecbae17713be239f86f
6 N7a5c661cfc7e4cd58e6800712e100a14
7 Na002c0f7ebb94cbb91df11db16a75fbc
8 Na32c9da7f4a64294bdb408c4cb058b92
9 Na940d07555c44fadb6f70c2e7c33de80
10 Nb8c9e8558895495b9811f7f8662f1db8
11 Nbf17a98a216548dcbf2a32bd37c21e84
12 Nc27f0135fd7744348c44b9601dc139e9
13 Ncd42683dca304f70800b5d436337fc3a
14 Ndbe2017026d2426ba497fd4c7f27022e
15 Ne3b9e456806041488028cad12977241b
16 Ne9c333b869fb46b08b57af5415cec561
17 Nf611b6a08a7241a8ab38673a7517ee91
18 anzsrc-for:11
19 anzsrc-for:1115
20 schema:author Na8bf102c934e42f8b0b265100c6f474e
21 schema:citation https://doi.org/10.1016/0046-8177(90)90073-e
22 https://doi.org/10.1016/0092-8674(91)90141-k
23 https://doi.org/10.1046/j.1365-2141.1996.d01-1951.x
24 https://doi.org/10.1073/pnas.84.21.7735
25 https://doi.org/10.1093/jnci/83.10.708
26 https://doi.org/10.1111/j.1365-2559.1991.tb00003.x
27 https://doi.org/10.1111/j.1600-0609.1992.tb00571.x
28 https://doi.org/10.1200/jco.1992.10.10.1635
29 schema:datePublished 1998-08
30 schema:datePublishedReg 1998-08-01
31 schema:description P-glycoprotein (Pgp)-related multidrug resistance (MDR) is frequently observed in acute non-lymphocytic leukemia (ANLL) and is associated with a poor response to standard chemotherapy. Cyclosporin A (CsA) is an effective downmodulator of Pgp-related MDR in vitro and has already been tested for that purpose in vivo also. Since Pgp is expressed in several normal cells and tissues, the modulation of Pgp can also modify total body exposure to antileukemic drugs and can alter and increase the toxicity of the antileukemic treatment. We report here the results of a study where 46 consecutive adult patients with ANLL were assigned to receive the same standard chemotherapy regimen of arabinosyl cytosine and idarubicin (IDA) for remission induction or consolidation, without or with CsA. Twenty-eight patients received 36 courses of chemotherapy without CsA and 18 patients received 32 courses of chemotherapy with CsA. CsA dose was 10-12.5 mg/kg/day and was given as a continuous i.v. infusion for 72 h. Whole blood CsA steady-state concentration ranged between 0.61 and 1.14 microM. The IDA area-under-the-curve was about twice as high in the cases that received CsA than in the other cases. CsA had no detectable effects on renal function and fluid balance, but significantly increased systemic blood diastolic pressure and conjugated bilirubine concentration. Furthermore, CsA-treated patients had greater, and more severe, oral and intestinal mucosal toxicity, with more severe adverse events, including more cases of gram-negative bacteremia, and with a delayed hemopoietic recovery. In conclusion, this study showed that an attempt at an effective downmodulation of Pgp-mediated MDR would substantially increase the hemopoietic and mucosal toxicity of antileukemic treatment and that the increase is accounted for, at least in part, by an increase of total body exposure to IDA.
32 schema:genre research_article
33 schema:inLanguage en
34 schema:isAccessibleForFree true
35 schema:isPartOf N0563d501d0424b059bf813b7d529ba8d
36 N346c1934ab714539a2472e36a8a81c87
37 sg:journal.1097065
38 schema:name Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia
39 schema:pagination 1236
40 schema:productId N194943364e8549658ac858e75794c2c6
41 N6eb06401de4a48bd9466b58aaf384b44
42 N77a876c7492940359d5d99c248921cfd
43 N858c033b1acb4a3a8ff2adad31197ee0
44 N8bf127849b6f4582ba9531e7c30880b7
45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026512234
46 https://doi.org/10.1038/sj.leu.2401092
47 schema:sdDatePublished 2019-04-11T11:57
48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
49 schema:sdPublisher N64740c20095f4061b973df0a983234d1
50 schema:url https://www.nature.com/articles/2401092
51 sgo:license sg:explorer/license/
52 sgo:sdDataset articles
53 rdf:type schema:ScholarlyArticle
54 N0563d501d0424b059bf813b7d529ba8d schema:issueNumber 8
55 rdf:type schema:PublicationIssue
56 N06a96a11416242a29de3ebcfbad360bb rdf:first sg:person.0734230340.16
57 rdf:rest N16444149891a4c86a82b0102819cbc6f
58 N108a7dec09d444b4acb03ff2eee82964 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Middle Aged
60 rdf:type schema:DefinedTerm
61 N16444149891a4c86a82b0102819cbc6f rdf:first sg:person.0725711337.51
62 rdf:rest N21a1867904a043d8b93fab409b9cb148
63 N194943364e8549658ac858e75794c2c6 schema:name readcube_id
64 schema:value 7e4e346c34f74a04d778987742d96852a2df290e234e53bbcab80ed8e708411a
65 rdf:type schema:PropertyValue
66 N21a1867904a043d8b93fab409b9cb148 rdf:first sg:person.01156366337.91
67 rdf:rest Naa51dba02be8484a9adcf83fb4c9b913
68 N299180e8dc8845f9b82fb6414abc0d3e rdf:first sg:person.01364770162.44
69 rdf:rest Ne314fda91c95484796ca400dbdd6b2ea
70 N2d8d323faf9343f08e81baacf1834260 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Antineoplastic Combined Chemotherapy Protocols
72 rdf:type schema:DefinedTerm
73 N346c1934ab714539a2472e36a8a81c87 schema:volumeNumber 12
74 rdf:type schema:PublicationVolume
75 N37cd50f1e7084af49be0284e19a52f6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Leukemia, Myeloid, Acute
77 rdf:type schema:DefinedTerm
78 N4aeeeead422949cfa04df2d86049648b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Female
80 rdf:type schema:DefinedTerm
81 N50383265672d4ecbae17713be239f86f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Chemotherapy, Adjuvant
83 rdf:type schema:DefinedTerm
84 N52b41f2f4dbb4132a00dda9018a09a86 rdf:first sg:person.0633657425.75
85 rdf:rest N869651923b9c4938a58cce7855f9c832
86 N64740c20095f4061b973df0a983234d1 schema:name Springer Nature - SN SciGraph project
87 rdf:type schema:Organization
88 N6da2745e8c7e403681bc5a163c8b5d44 rdf:first sg:person.01033477037.24
89 rdf:rest N299180e8dc8845f9b82fb6414abc0d3e
90 N6eb06401de4a48bd9466b58aaf384b44 schema:name nlm_unique_id
91 schema:value 8704895
92 rdf:type schema:PropertyValue
93 N77a876c7492940359d5d99c248921cfd schema:name dimensions_id
94 schema:value pub.1026512234
95 rdf:type schema:PropertyValue
96 N7a5c661cfc7e4cd58e6800712e100a14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Cytarabine
98 rdf:type schema:DefinedTerm
99 N858c033b1acb4a3a8ff2adad31197ee0 schema:name doi
100 schema:value 10.1038/sj.leu.2401092
101 rdf:type schema:PropertyValue
102 N869651923b9c4938a58cce7855f9c832 rdf:first sg:person.01310754205.76
103 rdf:rest N6da2745e8c7e403681bc5a163c8b5d44
104 N8bf127849b6f4582ba9531e7c30880b7 schema:name pubmed_id
105 schema:value 9697878
106 rdf:type schema:PropertyValue
107 Na002c0f7ebb94cbb91df11db16a75fbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Aged
109 rdf:type schema:DefinedTerm
110 Na32c9da7f4a64294bdb408c4cb058b92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Idarubicin
112 rdf:type schema:DefinedTerm
113 Na8bf102c934e42f8b0b265100c6f474e rdf:first sg:person.01104271471.84
114 rdf:rest N52b41f2f4dbb4132a00dda9018a09a86
115 Na940d07555c44fadb6f70c2e7c33de80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Treatment Outcome
117 rdf:type schema:DefinedTerm
118 Naa51dba02be8484a9adcf83fb4c9b913 rdf:first sg:person.01016466503.33
119 rdf:rest rdf:nil
120 Nb8c9e8558895495b9811f7f8662f1db8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Bilirubin
122 rdf:type schema:DefinedTerm
123 Nbf17a98a216548dcbf2a32bd37c21e84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Humans
125 rdf:type schema:DefinedTerm
126 Nc27f0135fd7744348c44b9601dc139e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Cyclosporine
128 rdf:type schema:DefinedTerm
129 Ncd42683dca304f70800b5d436337fc3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Adult
131 rdf:type schema:DefinedTerm
132 Ndbe2017026d2426ba497fd4c7f27022e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Creatinine
134 rdf:type schema:DefinedTerm
135 Ne314fda91c95484796ca400dbdd6b2ea rdf:first sg:person.0701003563.43
136 rdf:rest N06a96a11416242a29de3ebcfbad360bb
137 Ne3b9e456806041488028cad12977241b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Remission Induction
139 rdf:type schema:DefinedTerm
140 Ne9c333b869fb46b08b57af5415cec561 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 Nf611b6a08a7241a8ab38673a7517ee91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Feasibility Studies
145 rdf:type schema:DefinedTerm
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
150 schema:name Pharmacology and Pharmaceutical Sciences
151 rdf:type schema:DefinedTerm
152 sg:journal.1097065 schema:issn 0887-6924
153 1476-5551
154 schema:name Leukemia
155 rdf:type schema:Periodical
156 sg:person.01016466503.33 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
157 schema:familyName Baccarani
158 schema:givenName M
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016466503.33
160 rdf:type schema:Person
161 sg:person.01033477037.24 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
162 schema:familyName Russo
163 schema:givenName D
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033477037.24
165 rdf:type schema:Person
166 sg:person.01104271471.84 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
167 schema:familyName Damiani
168 schema:givenName D
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104271471.84
170 rdf:type schema:Person
171 sg:person.01156366337.91 schema:affiliation https://www.grid.ac/institutes/grid.5390.f
172 schema:familyName Furlanut
173 schema:givenName M
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156366337.91
175 rdf:type schema:Person
176 sg:person.01310754205.76 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
177 schema:familyName Ermacora
178 schema:givenName A
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310754205.76
180 rdf:type schema:Person
181 sg:person.01364770162.44 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
182 schema:familyName Fanin
183 schema:givenName R
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364770162.44
185 rdf:type schema:Person
186 sg:person.0633657425.75 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
187 schema:familyName Michieli
188 schema:givenName M
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633657425.75
190 rdf:type schema:Person
191 sg:person.0701003563.43 schema:affiliation https://www.grid.ac/institutes/grid.411492.b
192 schema:familyName Zaja
193 schema:givenName F
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701003563.43
195 rdf:type schema:Person
196 sg:person.0725711337.51 schema:affiliation https://www.grid.ac/institutes/grid.5390.f
197 schema:familyName Pea
198 schema:givenName F
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725711337.51
200 rdf:type schema:Person
201 sg:person.0734230340.16 schema:affiliation https://www.grid.ac/institutes/grid.5390.f
202 schema:familyName Baraldo
203 schema:givenName M
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734230340.16
205 rdf:type schema:Person
206 https://doi.org/10.1016/0046-8177(90)90073-e schema:sameAs https://app.dimensions.ai/details/publication/pub.1032819048
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/0092-8674(91)90141-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1042233556
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1046/j.1365-2141.1996.d01-1951.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1022338973
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1073/pnas.84.21.7735 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012281167
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1093/jnci/83.10.708 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059816490
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1111/j.1365-2559.1991.tb00003.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014389362
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1111/j.1600-0609.1992.tb00571.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016100757
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1200/jco.1992.10.10.1635 schema:sameAs https://app.dimensions.ai/details/publication/pub.1076202587
221 rdf:type schema:CreativeWork
222 https://www.grid.ac/institutes/grid.411492.b schema:alternateName Ospedale Santa Maria della Misericordia di Udine
223 schema:name Department of Bone Marrow Transplantation, Udine University Hospital, Italy
224 Division of Hematology, Department of Clinical and Morphologic Research, Udine University Hospital, Italy
225 rdf:type schema:Organization
226 https://www.grid.ac/institutes/grid.5390.f schema:alternateName University of Udine
227 schema:name Chair of Pharmacology, Department of Clinical and Experimental Pathology, Udine University, Italy
228 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...